Moyamoya disease epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 2: | Line 2: | ||
{{Moyamoya disease}} | {{Moyamoya disease}} | ||
{{CMG}} {{AE}} {{VVS}} | {{CMG}} {{AE}} {{VVS}} | ||
== | ==Epidemiology and Demographics== | ||
In Japan the overall incidence is higher (0.35 per 100,000).<ref name="pmid9409395">{{cite journal |author=Wakai K, Tamakoshi A, Ikezaki K, ''et al.'' |title=Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey |journal=[[Clin Neurol Neurosurg]] |volume=99 Suppl 2 |issue= |pages=S1–5 |year=1997 |pmid=9409395 |doi=10.1016/S0303-8467(97)00031-0}}</ref> It is more common in women than in men, although about a third of those affected are male .<ref name="pmid18048855">{{cite journal |author=Kuriyama S, Kusaka Y, Fujimura M, ''et al.'' |title=Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey |journal=Stroke |volume=39 |issue=1 |pages=42–7 |year=2008 |pmid=18048855 |doi=10.1161/STROKEAHA.107.490714 |url=http://stroke.ahajournals.org/cgi/pmidlookup?view=long&pmid=18048855}}</ref> It is a disease that tends to affect children and adults in the third to fourth decades of life. In children it tends to cause strokes or seizures. In adults it tends to cause strokes or bleeding. Women frequently experience transient ischemic attacks (TIA), cerebral hemorrhage or no symptoms. They have a higher risk of recurrent stroke and may be experiencing a distinct underlying pathophysiology compared to patients from Japan. Data suggest a potential benefit with surgery if early diagnosis is made.<ref name="pmid16645133">{{cite journal |author=Hallemeier C, Rich K, Brubb R, Chicoine M, Moran C, Cross D, Zipfel G, Dacey R, Derdeyn |title=Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey |journal=[[Stroke]] |volume=37 |issue= 6|pages=1490–1496 |year=2006 |pmid=16645133 |doi=10.1161/01.STR.0000221787.70503.ca}}</ref> | In Japan the overall incidence is higher (0.35 per 100,000).<ref name="pmid9409395">{{cite journal |author=Wakai K, Tamakoshi A, Ikezaki K, ''et al.'' |title=Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey |journal=[[Clin Neurol Neurosurg]] |volume=99 Suppl 2 |issue= |pages=S1–5 |year=1997 |pmid=9409395 |doi=10.1016/S0303-8467(97)00031-0}}</ref> It is more common in women than in men, although about a third of those affected are male .<ref name="pmid18048855">{{cite journal |author=Kuriyama S, Kusaka Y, Fujimura M, ''et al.'' |title=Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey |journal=Stroke |volume=39 |issue=1 |pages=42–7 |year=2008 |pmid=18048855 |doi=10.1161/STROKEAHA.107.490714 |url=http://stroke.ahajournals.org/cgi/pmidlookup?view=long&pmid=18048855}}</ref> It is a disease that tends to affect children and adults in the third to fourth decades of life. In children it tends to cause strokes or seizures. In adults it tends to cause strokes or bleeding. Women frequently experience transient ischemic attacks (TIA), cerebral hemorrhage or no symptoms. They have a higher risk of recurrent stroke and may be experiencing a distinct underlying pathophysiology compared to patients from Japan. Data suggest a potential benefit with surgery if early diagnosis is made.<ref name="pmid16645133">{{cite journal |author=Hallemeier C, Rich K, Brubb R, Chicoine M, Moran C, Cross D, Zipfel G, Dacey R, Derdeyn |title=Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey |journal=[[Stroke]] |volume=37 |issue= 6|pages=1490–1496 |year=2006 |pmid=16645133 |doi=10.1161/01.STR.0000221787.70503.ca}}</ref> | ||
Revision as of 15:59, 26 February 2013
|
Moyamoya disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Moyamoya disease epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Moyamoya disease epidemiology and demographics |
|
Risk calculators and risk factors for Moyamoya disease epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Vishnu Vardhan Serla M.B.B.S. [2]
Epidemiology and Demographics
In Japan the overall incidence is higher (0.35 per 100,000).[1] It is more common in women than in men, although about a third of those affected are male .[2] It is a disease that tends to affect children and adults in the third to fourth decades of life. In children it tends to cause strokes or seizures. In adults it tends to cause strokes or bleeding. Women frequently experience transient ischemic attacks (TIA), cerebral hemorrhage or no symptoms. They have a higher risk of recurrent stroke and may be experiencing a distinct underlying pathophysiology compared to patients from Japan. Data suggest a potential benefit with surgery if early diagnosis is made.[3]
References
- ↑ Wakai K, Tamakoshi A, Ikezaki K; et al. (1997). "Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey". Clin Neurol Neurosurg. 99 Suppl 2: S1–5. doi:10.1016/S0303-8467(97)00031-0. PMID 9409395.
- ↑ Kuriyama S, Kusaka Y, Fujimura M; et al. (2008). "Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey". Stroke. 39 (1): 42–7. doi:10.1161/STROKEAHA.107.490714. PMID 18048855.
- ↑ Hallemeier C, Rich K, Brubb R, Chicoine M, Moran C, Cross D, Zipfel G, Dacey R, Derdeyn (2006). "Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey". Stroke. 37 (6): 1490–1496. doi:10.1161/01.STR.0000221787.70503.ca. PMID 16645133.